Table 2

Distribution of cell cycle phase in response to genistein treatment in vitro

Cell lines and treatmentG1S phaseG2-M
E6
Control59 ± 417 ± 225 ± 4
G1066 ± 511 ± 223 ± 3
G2057 ± 714 ± 228 ± 4
RT4
Control56 ± 119 ± 124 ± 1
G1058 ± 122 ± 323 ± 2
G2052 ± 215 ± 334 ± 2
TSGH-8301
Control45 ± 229 ± 726 ± 7
G107 ± 726 ± 163 ± 7a,b
G203 ± 436 ± 464 ± 6b,c
T24
Control48 ± 342 ± 613 ± 4
G1040 ± 230 ± 831 ± 6a
G2010 ± 222 ± 769 ± 4b,c
J82
Control40 ± 237 ± 211 ± 1
G1017 ± 134 ± 347 ± 1a,b
G2013 ± 326 ± 258 ± 3b,c
  • a P < 0.05 compared with E6 cell line treated with 10 μg/ml GE.

  • b P < 0.05 compared with the control (without treatment with genistein).

  • c P < 0.05 compared with the E6 cell line treated with 20 μg/ml GE.